Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III

Cancer Causes and Control

Volumn 21, Issue 10, 2010, Pages 1575-1583

  Mondul, Alison M ^a   Selvin, Elizabeth ^a,b   Rohrmann, Sabine ^c   Menke, Andy ^a,b   Feinleib, Manning ^a   Kanarek, Norma ^a,d   Rifai, Nader ^e   Dobs, Adrian S ^f   Platz, Elizabeth A ^a,d,g  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cholesterol; Cross sectional studies; Gonadal steroid hormones; Hydroxymethylglutaryl CoA reductases; Prostatic neoplasms

Indexed keywords

CHOLESTEROL; ESTRADIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEX HORMONE; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ETHNICITY; HEALTH SURVEY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CROSS-SECTIONAL STUDIES; ESTRADIOL; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROSTATIC NEOPLASMS; RISK; TESTOSTERONE;

EID: 77956974044     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9586-6     Document Type: Article

References (55)

1. MF Demierre PD Higgins SB Gruber E Hawk SM Lippman 2005 Statins and cancer prevention Nat Rev Cancer 5 12 930 942 1:CAS:528:DC%2BD2MXht1ykurbL 10.1038/nrc1751 16341084
2. KR Solomon MR Freeman 2008 Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19 4 113 121 1:CAS:528:DC%2BD1cXlslWrsro%3D 10.1016/j.tem.2007.12.004 18356074
3. WG Nelson 2007 Prostate cancer prevention Curr Opin Urol 17 3 157 167 10.1097/MOU.0b013e3280eb110f 17414513
4. SA Hall ST Page TG Travison, et al. 2007 Do statins affect androgen levels in men? Results from the Boston area community health survey Cancer Epidemiol Biomarkers Prev 16 8 1587 1594 1:CAS:528:DC%2BD2sXos1equ70%3D 10.1158/1055-9965.EPI-07-0306 17684132
5. WH Farnsworth JM Hoeg M Maher, et al. 1987 Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin J Clin Endocrinol Metab 65 3 546 550 1:STN:280:DyaL2szgvVKnug%3D%3D 10.1210/jcem-65-3-546 3114306
6. G Mastroberardino C Costa MS Gavelli, et al. 1989 Plasma cortisol and testosterone in hypercholesterolaemia treated with clofibrate and lovastatin J Int Med Res 17 4 388 394 1:STN:280:DyaK3c%2Fgs1eruw%3D%3D 2676654
7. RH Jay RH Sturley C Stirling, et al. 1991 Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia Br J Clin Pharmacol 32 4 417 422 1:STN:280: DyaK38%2FmvVKqsQ%3D%3D 1958433
8. C Azzarito L Boiardi M Zini, et al. 1992 Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patients Metabolism 41 2 148 153 1:STN:280: DyaK387ktVSmug%3D%3D 10.1016/0026-0495(92)90143-X 1310516
9. K Purvis A Tollefsrud H Rui, et al. 1992 Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia Eur J Clin Pharmacol 42 1 61 64 1:STN:280: DyaK387nsFSgtA%3D%3D 10.1007/BF00314921 1541317
10. AS Dobs S Miller G Neri, et al. 2000 Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients Metabolism 49 1 115 121 1:CAS:528:DC%2BD3cXltF2lsw%3D%3D 10.1016/S0026-0495(00)90938-7 10647074
11. SA Santini C Carrozza P Lulli, et al. 2003 Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia J Atheroscler Thromb 10 3 160 164 1:CAS:528:DC%2BD3sXnvVKjsrg%3D 14564085
12. M Bohm W Herrmann S Wassmann U Laufs G Nickenig 2004 Does statin therapy influence steroid hormone synthesis? Z Kardiol 93 1 43 48 1:STN:280: DC%2BD2c%2FktValsA%3D%3D 10.1007/s00392-004-1003-2 14740240
13. AS Dobs H Schrott MH Davidson, et al. 2000 Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia Metabolism 49 9 1234 1238 1:CAS:528:DC%2BD3cXms1ynsLY%3D 10.1053/meta.2000.7716a 11016911
14. MT Hyyppa E Kronholm A Virtanen A Leino A Jula 2003 Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial Psychoneuroendocrinology 28 2 181 194 1:CAS:528: DC%2BD38XpvVWmtrc%3D 10.1016/S0306-4530(02)00014-8 12510011
15. T Ormiston OM Wolkowitz VI Reus R Johnson F Manfredi 2004 Hormonal changes with cholesterol reduction: a double-blind pilot study J Clin Pharm Ther 29 1 71 73 1:CAS:528:DC%2BD2cXitVykt7g%3D 10.1111/j.1365-2710.2003.00540.x 14748901
16. C Azzarito L Boiardi W Vergoni M Zini I Portioli 1996 Testicular function in hypercholesterolemic male patients during prolonged simvastatin treatment Horm Metab Res 28 4 193 198 1:CAS:528:DyaK28Xjt1Gmsrs%3D 10.1055/s-2007-979159 8740196
17. AS Dobs PS Sarma D Schteingart 1993 Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Metabolism 42 9 1146 1152 1:STN:280:DyaK2c%2FhvVOhsg%3D%3D 10.1016/0026-0495(93)90272-P 8412767
18. RF Heller NE Miller B Lewis, et al. 1981 Associations between sex hormones, thyroid hormones and lipoproteins Clin Sci (Lond) 61 5 649 651 1:CAS:528:DyaL38XmtlWlug%3D%3D
19. RF Heller MJ Wheeler J Micallef NE Miller B Lewis 1983 Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone binding globulin Acta Endocrinol (Copenh) 104 2 253 256 1:STN:280:DyaL2c%2FkvVSquw%3D%3D
20. WS Dai JP Gutai LH Kuller, et al. 1984 Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in men Am J Cardiol 53 9 1259 1263 1:CAS:528:DyaL2cXktVWjur0%3D 10.1016/0002-9149(84)90075-4 6711424
21. E Hamalainen H Adlercreutz C Ehnholm P Puska 1986 Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men Metabolism 35 6 535 541 1:CAS:528:DyaL28XitVSmsbo%3D 10.1016/0026-0495(86)90011-9 3086660
22. MJ Lichtenstein JW Yarnell PC Elwood, et al. 1987 Sex hormones, insulin, lipids, and prevalent ischemic heart disease Am J Epidemiol 126 4 647 657 1:STN:280:DyaL2szitlWruw%3D%3D 3307391
23. ML Stefanick PT Williams RM Krauss, et al. 1987 Relationships of plasma estradiol, testosterone, and sex hormone-binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein subfractions in men J Clin Endocrinol Metab 64 4 723 729 1:CAS:528:DyaL2sXhs12gs7w%3D 10.1210/jcem-64-4-723 3818901
24. E Barrett-Connor KT Khaw 1988 Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study Circulation 78 3 539 545 1:STN:280:DyaL1czhtFCgsw%3D%3D 3409497
25. DP Kiel JA Baron SR Plymate CG Chute 1989 Sex hormones and lipoproteins in men Am J Med 87 1 35 39 1:STN:280:DyaL1MzgtVynsg%3D%3D 10.1016/S0002-9343(89) 80480-2 2787120
26. MN Nanjee J Rajput-Williams L Samuel R Wootton NE Miller 1989 Relationships of plasma lipoprotein concentrations to unbound, albumin-bound and sex hormone-binding globulin-bound fractions of gonadal steroids in men Eur J Clin Invest 19 3 241 245 1:STN:280:DyaK3c%2Fjt1ymtQ%3D%3D 10.1111/j.1365-2362. 1989.tb00224.x 2509209
27. DS Freedman TR O'Brien WD Flanders F DeStefano JJ Barboriak 1991 Relation of serum testosterone levels to high density lipoprotein cholesterol and other characteristics in men Arterioscler Thromb 11 2 307 315 1:CAS:528: DyaK3MXhvF2qsrs%3D 1998648
28. KT Khaw E Barrett-Connor 1991 Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men Arterioscler Thromb 11 3 489 494 1:CAS:528:DyaK3MXks1Cqu7o%3D 2029491
29. I Kato A Nomura GN Stemmermann PH Chyou 1992 Determinants of sex hormone levels in men as useful indices in hormone-related disorders J Clin Epidemiol 45 12 1417 1421 1:STN:280:DyaK3s%2FpsVymtg%3D%3D 10.1016/0895-4356(92)90203-Y 1460479
30. A Tchernof F Labrie A Belanger, et al. 1997 Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables Atherosclerosis 133 2 235 244 1:CAS:528:DyaK2sXlslentrk%3D 10.1016/S0021-9150(97)00125-1 9298684
31. JM Zmuda JA Cauley A Kriska, et al. 1997 Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants Am J Epidemiol 146 8 609 617 1:STN:280:DyaK1c%2FgsVyksQ%3D%3D 9345114
32. JK Wranicz I Cygankiewicz M Rosiak, et al. 2005 The relationship between sex hormones and lipid profile in men with coronary artery disease Int J Cardiol 101 1 105 110 10.1016/j.ijcard.2004.07.010 15860391
33. A Nordoy A Aakvaag D Thelle 1979 Sex hormones and high density lipoproteins in healthy males Atherosclerosis 34 4 431 436 1:STN:280: DyaL3c%2Fosl2ksw%3D%3D 10.1016/0021-9150(79)90067-4 229880
34. S Deutscher MW Bates MJ Caines, et al. 1986 Determinants of lipid and lipoprotein level in elderly men Atherosclerosis 60 3 221 229 1:CAS:528:DyaL28XksVSjs7c%3D 10.1016/0021-9150(86)90169-3 3730043
35. I Van Pottelbergh L Braeckman D De Bacquer G De Backer JM Kaufman 2003 Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men Atherosclerosis 166 1 95 102 10.1016/S0021-9150(02)00308-8 12482555
36. SG Mendoza A Zerpa H Carrasco, et al. 1983 Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion Artery 12 1 1 23 1:STN:280:DyaL2c3nvFCnsQ%3D%3D 6431945
37. SM Haffner L Mykkanen RA Valdez MS Katz 1993 Relationship of sex hormones to lipids and lipoproteins in nondiabetic men J Clin Endocrinol Metab 77 6 1610 1615 1:CAS:528:DyaK2cXks1WrsQ%3D%3D 10.1210/jc.77.6.1610 8263149
38. National Cholesterol Education Program (2001) Expert panel on detection evaluation, and treatment of high blood cholesterol in adults. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). NIH publication. The Program, Bethesda, MD
39. Beers MH, Berkow R, Merck Research L (1999) The Merck manual of diagnosis and therapy. In: Anonymous (ed). Merck Research Laboratories, Whitehouse Station
40. S Rinaldi A Geay H Dechaud, et al. 2002 Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations Cancer Epidemiol Biomarkers Prev 11 10 Pt 1 1065 1071 1:CAS:528:DC%2BD38Xos1ekurs%3D 12376508
41. A Vermeulen L Verdonck JM Kaufman 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 10 3666 3672 1:CAS:528:DyaK1MXms1Ohtbs%3D 10.1210/jc.84.10.3666 10523012
42. Gunter EW, Lewis BG, Koncikowski SM (1996) Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Report. Centers for Disease Control and Prevention, Hyattsville, MD
43. WC Chumlea SS Guo RJ Kuczmarski, et al. 2002 Body composition estimates from NHANES III bioelectrical impedance data Int J Obes Relat Metab Disord 26 12 1596 1609 1:STN:280:DC%2BD38npvFCgtg%3D%3D 10.1038/sj.ijo.0802167 12461676
44. American Heart Association (2008) What your cholesterol levels mean. American Hearth Association
45. GP Bernini G Brogi GF Argenio A Moretti A Salvetti 1998 Effects of long-term pravastatin treatment on spermatogenesis and on adrenal and testicular steroidogenesis in male hypercholesterolemic patients J Endocrinol Invest 21 5 310 317 1:CAS:528:DyaK1cXktlClsrc%3D 9648053
46. A Segarra P Chacon M Vilardell LL Piera 1996 Prospective case control study to determine the effect of lovastatin on serum testosterone and cortisol concentrations in hyperlipidemic nephrotic patients with chronic renal failure Nephron 73 2 186 190 1:CAS:528:DyaK28XjvFynurc%3D 10.1159/000189038 8773342
47. D Travia F Tosi C Negri, et al. 1995 Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads J Clin Endocrinol Metab 80 3 836 840 1:CAS:528:DyaK2MXktlOnt7Y%3D 10.1210/jc.80.3.836 7883839
48. E Selvin M Feinleib L Zhang, et al. 2007 Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III) Diabetes Care 30 2 234 238 1:CAS:528:DC%2BD2sXitlaju7o%3D 10.2337/dc06-1579 17259487
49. J Shannon S Tewoderos M Garzotto, et al. 2005 Statins and prostate cancer risk: a case-control study Am J Epidemiol 162 4 318 325 10.1093/aje/kwi203 16014776
50. EA Platz MF Leitzmann K Visvanathan, et al. 2006 Statin drugs and risk of advanced prostate cancer J Natl Cancer Inst 98 24 1819 1825 1:CAS:528:DC%2BD28XhtlCru7bO 10.1093/jnci/djj499 17179483
51. ED Flick LA Habel KA Chan, et al. 2007 Statin use and risk of prostate cancer in the California Men's Health Study cohort Cancer Epidemiol Biomarkers Prev 16 11 2218 2225 1:CAS:528:DC%2BD2sXhtlSmur3N 10.1158/1055-9965.EPI-07-0197 17971519
52. EJ Jacobs C Rodriguez EB Bain, et al. 2007 Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort Cancer Epidemiol Biomarkers Prev 16 11 2213 2217 1:CAS:528:DC%2BD2sXhtlSmur3M 10.1158/1055-9965.EPI-07-0448 17971518
53. TJ Murtola TL Tammela J Lahtela A Auvinen 2007 Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study Cancer Epidemiol Biomarkers Prev 16 11 2226 2232 1:CAS:528:DC%2BD2sXhtlSmur3O 10.1158/1055-9965.EPI-07-0599 18006910
54. GD Friedman ED Flick N Udaltsova, et al. 2008 Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients Pharmacoepidemiol Drug Saf 17 1 27 36 10.1002/pds.1507 17944002
55. JE Edwards RA Moore 2003 Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials BMC Fam Pract 4 18 10.1186/1471-2296-4-18 14969594